Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Ocrelizumab> ?p ?o }
Showing triples 1 to 85 of
85
with 100 triples per page.
- Ocrelizumab abstract "Ocrelizumab is a humanized anti-CD20 monoclonal antibody. It targets mature B lymphocytes and hence is an immunosuppressive drug candidate. It is under development by Hoffmann–La Roche's subsidiary Genentech, and Biogen Idec.It had reached Phase III clinical trials for rheumatoid arthritis and lupus erythematosus, and Phase II for multiple sclerosis (MS) and hematological cancer.In March 2010, Roche announced the suspension of clinical trials in rheumatoid arthritis and lupus erythematosus. This step followed excess deaths due to opportunistic infections. Development for multiple sclerosis continues.In October 2010, Roche announced 24-week results from the PhII study in relapse remitting MS. The drug demonstrated a statistically significant reduction in disease activity as measured by brain lesions (measured by MRI scans) and relapse rate compared to placebo. Both doses (200 mg and 600 mg) were well tolerated.".
- Ocrelizumab atcPrefix "none".
- Ocrelizumab casNumber "637334-45-3".
- Ocrelizumab fdaUniiCode "A10SJL62JY".
- Ocrelizumab wikiPageID "9134156".
- Ocrelizumab wikiPageLength "4019".
- Ocrelizumab wikiPageOutDegree "22".
- Ocrelizumab wikiPageRevisionID "640682826".
- Ocrelizumab wikiPageWikiLink Atomic_mass_unit.
- Ocrelizumab wikiPageWikiLink B_cell.
- Ocrelizumab wikiPageWikiLink Biogen.
- Ocrelizumab wikiPageWikiLink Biogen_Idec.
- Ocrelizumab wikiPageWikiLink CD20.
- Ocrelizumab wikiPageWikiLink CD20_antagonist.
- Ocrelizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Ocrelizumab wikiPageWikiLink Clinical_trial.
- Ocrelizumab wikiPageWikiLink Genentech.
- Ocrelizumab wikiPageWikiLink Hematological_cancer.
- Ocrelizumab wikiPageWikiLink Hoffmann-La_Roche.
- Ocrelizumab wikiPageWikiLink Hoffmann–La_Roche.
- Ocrelizumab wikiPageWikiLink Humanized_antibody.
- Ocrelizumab wikiPageWikiLink Immunosuppressive_drug.
- Ocrelizumab wikiPageWikiLink Intravenous_infusion.
- Ocrelizumab wikiPageWikiLink Intravenous_therapy.
- Ocrelizumab wikiPageWikiLink KDa.
- Ocrelizumab wikiPageWikiLink Lupus_erythematosus.
- Ocrelizumab wikiPageWikiLink Magnetic_resonance_imaging.
- Ocrelizumab wikiPageWikiLink Monoclonal_antibody.
- Ocrelizumab wikiPageWikiLink Multiple_sclerosis.
- Ocrelizumab wikiPageWikiLink Ofatumumab.
- Ocrelizumab wikiPageWikiLink Opportunistic_infection.
- Ocrelizumab wikiPageWikiLink Rheumatoid_arthritis.
- Ocrelizumab wikiPageWikiLink Rituximab.
- Ocrelizumab wikiPageWikiLink Tumors_of_the_hematopoietic_and_lymphoid_tissues.
- Ocrelizumab wikiPageWikiLinkText "Ocrelizumab".
- Ocrelizumab wikiPageWikiLinkText "ocrelizumab".
- Ocrelizumab atcPrefix "none".
- Ocrelizumab c "6494".
- Ocrelizumab casNumber "637334".
- Ocrelizumab chemspiderid "NA".
- Ocrelizumab h "9978".
- Ocrelizumab hasPhotoCollection Ocrelizumab.
- Ocrelizumab legalStatus "Investigational".
- Ocrelizumab mabType "mab".
- Ocrelizumab molecularWeight "148".
- Ocrelizumab n "1718".
- Ocrelizumab o "2014".
- Ocrelizumab routesOfAdministration Intravenous_infusion.
- Ocrelizumab routesOfAdministration Intravenous_therapy.
- Ocrelizumab s "46".
- Ocrelizumab source "zu/o".
- Ocrelizumab target CD20.
- Ocrelizumab type "mab".
- Ocrelizumab unii "A10SJL62JY".
- Ocrelizumab verifiedfields "changed".
- Ocrelizumab verifiedrevid "458282664".
- Ocrelizumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Ocrelizumab wikiPageUsesTemplate Template:Distinguish.
- Ocrelizumab wikiPageUsesTemplate Template:Drugbox.
- Ocrelizumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Ocrelizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Ocrelizumab wikiPageUsesTemplate Template:Reflist.
- Ocrelizumab subject Category:Monoclonal_antibodies.
- Ocrelizumab hypernym Antibody.
- Ocrelizumab type Article.
- Ocrelizumab type ChemicalSubstance.
- Ocrelizumab type Drug.
- Ocrelizumab type Antibody.
- Ocrelizumab type Article.
- Ocrelizumab type Chemical.
- Ocrelizumab type Drug.
- Ocrelizumab type ChemicalObject.
- Ocrelizumab type Thing.
- Ocrelizumab type Q8386.
- Ocrelizumab comment "Ocrelizumab is a humanized anti-CD20 monoclonal antibody. It targets mature B lymphocytes and hence is an immunosuppressive drug candidate. It is under development by Hoffmann–La Roche's subsidiary Genentech, and Biogen Idec.It had reached Phase III clinical trials for rheumatoid arthritis and lupus erythematosus, and Phase II for multiple sclerosis (MS) and hematological cancer.In March 2010, Roche announced the suspension of clinical trials in rheumatoid arthritis and lupus erythematosus.".
- Ocrelizumab label "Ocrelizumab".
- Ocrelizumab differentFrom Eculizumab.
- Ocrelizumab sameAs أوكرليزوماب.
- Ocrelizumab sameAs Ocrelizumab.
- Ocrelizumab sameAs m.027yysd.
- Ocrelizumab sameAs Окрелизумаб.
- Ocrelizumab sameAs Q2013780.
- Ocrelizumab sameAs Q2013780.
- Ocrelizumab wasDerivedFrom Ocrelizumab?oldid=640682826.
- Ocrelizumab isPrimaryTopicOf Ocrelizumab.